Max Wiznitzer, MD, is a pediatric neurologist in the Neurologic Institute at University Hospitals Rainbow Babies and Children's Hospital. He is Professor of Pediatrics and Neurology, Case Western Reserve University School of Medicine.
Dr. Wiznitzer is board certified in pediatrics, neurology with special qualification in child neurology, and neurodevelopmental disabilities His special interests include attention deficit-hyperactivity disorder (ADHD), autism spectrum disorders, developmental and behavioral disorders and pediatric neurology. He was named to the UH Rainbow Babies and Children's Hospital staff in 1986.
Dr. Wiznitzer earned a bachelor’s degree in medical education from Northwestern University, Evanston, Ill., and his medical degree from Northwestern University Medical School. He completed a residency in pediatrics and a fellowship in developmental disorders at Children's Hospital Medical Center, Cincinnati, Ohio, and a fellowship in pediatric neurology at Children's Hospital of Philadelphia, Philadelphia, Pa. He completed his postdoctoral training as a National Institutes of Health National Research fellow in higher cortical functions at Albert Einstein College of Medicine, Bronx, N.Y.
His research interests include autism and pediatric stroke. He has served as Principal Investigator, co-investigator and a consultant on research studies in these areas funded by the National Institutes of Health and other institutions.
Dr. Wiznitzer has authored or coauthored 11 textbook chapters and nearly 70 scientific papers in leading medical journals. He is a reviewer for Neurology, Journal of Child Neurology, Pediatric Neurology, Pediatrics, Lancet Neurology and Brain and serves on several editorial boards. He has presented more than 50 abstracts at national medical meetings and more than 200 lectures to medical meetings as well as community, parent and education groups, speaking on autism, ADHD and other topics in pediatric neurology and development.
Dr. Wiznitzer is a member of the American Academy of Pediatrics, American Academy of Neurology, Child Neurology Society and the Society of Developmental Behavioral Pediatrics.
Awards and Recognition
1991 Professional of the Year, Autism Society of Ohio
American Board of Psychiatry and Neurology - Neurology with Special Qualifications in Child Neurology
American Board of Pediatrics - Pediatrics
American Board of Psychiatry and Neurology - Neurodevelopmental Disabilities
Education & Training
1975, Northwestern University
Medical / Professional School(s)
1977, Northwestern University Feinberg School of Medicine
1980, Pediatrics - Cincinnati Children's Hospital Medical Center
1984, Pediatric Neurology - Children's Hospital of Philadelphia
1981, Developmental Disabilities - Cincinnati Children's Hospital Medical Center
1986, Clinical Epidemiology - Pediatric - Albert Einstein College of Medicine of Yeshiva University
Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorders and Related Disorders, Developmental and Behavioral Disorders, Pediatric Neurology, EEG - Electroencephalography
UH Rainbow Babies and Children's Hospital
Department of Pediatrics-Neurology
11100 Euclid Ave
5850 Landerbrook Dr
UH Landerbrook Health Center, Ste 220
Rainbow Specialties Center
960 Clague Rd
UH Westlake Health Center, Bldg A, Ste 1600
Firelands Regional Hospital
1912 Hayes Ave
Pediatric Neurology Clinic
4001 Carrick Rd
UH Medina Health Center, Ste 220
UH Rainbow Physicians and Surgeons
4137 Boardman-Canfield Rd
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Max Wiznitzer, MD disclosed the following Outside Relationships with Industry:
Novartis Pharmaceuticals - Consulting